Cargando…
Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
BACKGROUND: As the World Health Organization seeks to eliminate trachoma by 2020, countries are beginning to control the transmission of trachomatous inflammation–follicular (TF) and discontinue mass drug administration (MDA) with oral azithromycin. We evaluated the effect of MDA discontinuation on...
Autores principales: | Godwin, William, Prada, Joaquin M, Emerson, Paul, Hooper, P J, Bakhtiari, Ana, Deiner, Michael, Porco, Travis C, Mahmud, Hamidah, Landskroner, Emma, Hollingsworth, T Déirdre, Medley, Graham F, Pinsent, Amy, Bailey, Robin, Lietman, Thomas M, Oldenburg, Catherine E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289551/ https://www.ncbi.nlm.nih.gov/pubmed/32052842 http://dx.doi.org/10.1093/infdis/jiz691 |
Ejemplares similares
-
Erratum to: Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020) -
Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination
por: Lietman, Thomas M, et al.
Publicado: (2018) -
Forecasting Trachoma Control and Identifying Transmission-Hotspots
por: Blumberg, Seth, et al.
Publicado: (2021) -
Stopping azithromycin mass drug administration for trachoma: A systematic review
por: Mahmud, Hamidah, et al.
Publicado: (2021) -
Implications of the COVID-19 pandemic on eliminating trachoma as a public health problem
por: Blumberg, Seth, et al.
Publicado: (2020)